Lunai Bioworks (LNAI) Total Current Liabilities (2011 - 2026)
Lunai Bioworks (LNAI) posted quarterly Total Current Liabilities of $19.3 million for Q1 2026, down 33.14% year-over-year from $28.8 million in Q1 2025, and down 3.59% quarter-over-quarter from $20.0 million in Q4 2025.
Lunai Bioworks (LNAI) Total Current Liabilities (2011 - 2026) Analysis & Trends
Lunai Bioworks' Total Current Liabilities history runs 16 years deep, the most recent figure standing at $19.3 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 33.14% year-over-year to $19.3 million; the TTM figure through Mar 2026 stood at $19.3 million (down 33.14% YoY), while the FY2025 annual figure was $29.2 million, down 3.81% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $19.3 million, down from $20.0 million in the prior quarter.
- The five-year high for Total Current Liabilities was $30.3 million in Q2 2024, with the low at $6.5 million in Q2 2022.
- The 5-year median for Total Current Liabilities is $19.3 million (2026), against an average of $17.6 million.
- The sharpest annual moves came in 2022 and 2026: Total Current Liabilities jumped 491.4% in 2022, then plunged 33.14% in 2026.
- Lunai Bioworks' Total Current Liabilities stood at $11.3 million in 2022, then rose by 21.84% to $13.8 million in 2023, then jumped by 107.92% to $28.6 million in 2024, then slumped by 30.08% to $20.0 million in 2025, then decreased by 3.59% to $19.3 million in 2026.
- Business Quant data shows LNAI's Total Current Liabilities at $19.3 million in Q1 2026, $20.0 million in Q4 2025, and $19.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.51 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 438.74 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 630.93 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 2.49 Bn |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | 19.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.28 Mn |
| Dec 31, 2025 | 20.00 Mn |
| Sep 30, 2025 | 19.72 Mn |
| Jun 30, 2025 | 29.16 Mn |
| Mar 31, 2025 | 28.84 Mn |
| Dec 31, 2024 | 28.61 Mn |
| Sep 30, 2024 | 23.04 Mn |
| Jun 30, 2024 | 30.31 Mn |
| Mar 31, 2024 | 20.87 Mn |
| Dec 31, 2023 | 13.76 Mn |
| Sep 30, 2023 | 10.10 Mn |
| Jun 30, 2023 | 11.02 Mn |
| Mar 31, 2023 | 11.77 Mn |
| Dec 31, 2022 | 11.29 Mn |
| Sep 30, 2022 | 7.16 Mn |
| Jun 30, 2022 | 6.45 Mn |
| Mar 31, 2022 | 7.51 Mn |
| Dec 31, 2021 | 6.20 Mn |
| Sep 30, 2021 | 1.21 Mn |
| Jun 30, 2021 | 1.89 Mn |